Anti-interleukin-2 receptor monoclonal antibody 33B3-1

N/A

Report date: 2022/02/21 13:37:45

Base Information

Drug NameAnti-interleukin-2 receptor monoclonal antibody 33B3-1

Drug Alias NameAnti-CD25 monoclonal antibody 33B3.133B3.1Interleukin-2 receptor monoclonal antibody 33B3.1

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionInterleukin-2 receptor alpha chain inhibitors

TargetsInterleukin-2 receptor alpha chain

Therapy Area/IndicationsRejection of organ transplantation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesImmunotech SAS

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesImmunotech SAS

Active IndicationsN/A

Inactive IndicationsRejection of organ transplantation

ATC CodeN/A